Back to Agenda
Off-Label Communications to Health Care Providers and Consumers
Session Chair(s)
John Kamp
Washington Counsel, Coalition For Healthcare Communication (CHC), United States
Preparing for new FDA policies on off-label communication to health care providers and consumers in light of FDA, court, and other developments.
Learning Objective : Discuss the newest developments at FDA and industry recommendations for changes in FDA off-label policies.
Speaker(s)
Todd M. Hobbs, DrMed
Vice President, Chief Medial Officer, Novo Nordisk A/S, United States
Scientific Exchange in the Digital Age
Kellie B. Combs, JD
Partner, Ropes & Gray LLP, United States
Panelist
James M. Spears, JD
, Consultant, United States
Beyond the Product Label
Have an account?